/PRNewswire/ MingMed Biotechnology, a clinical stage company dedicated to developing First-in-Class pharmaceutical products, today announced that Ms. Liza.
/PRNewswire/ MingMed Biotechnology, a clinical stage company dedicated to developing First-in-Class pharmaceutical products, today announced that Ms. Liza.
GUANGZHOU, China, Jan. 5, 2022 /PRNewswire/ MingMed Biotechnology, a clinical stage company dedicated to developing First-in-Class pharmaceutical products, today announced that Ms. Liza Ko
China Digest: MingMed raises $50m; Hongtai Aplus backs RCD dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.